24 Chapter 1 53. Gauthier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. Journal of immunology (Baltimore, Md: 1950). 1996;156(3):1151-6. 54. Gao Q, Zeng Q, Wang Z, Li C, Xu Y, Cui P, et al. Circulating cell-free DNA for cancer early detection. The Innovation. 2022;3(4):100259. 55. Du Clos T, Volzer M, Hahn F, Xiao R, Mold C, Searles R. Chromatin clearance in C57Bl/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells. Clinical & Experimental Immunology. 1999;117(2):403-11. 56. Han DSC, Lo YMD. The Nexus of cfDNA and Nuclease Biology. Trends in Genetics. 2021;37(8):758-70. 57. Botezatu I, Serdyuk Og, Potapova G, Shelepov V, Alechina R, Molyaka Y, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clinical chemistry. 2000;46(8):1078-84. 58. Dermody SM, Bhambhani C, Swiecicki PL, Brenner JC, Tewari M. Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer. Front Genet. 2022;13:879108. 59. Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular Cancer. 2022;21(1):79. 60. Cohen SA, Liu MC, Aleshin A. Practical recommendations for using ctDNA in clinical decision making. Nature. 2023;619(7969):259-68. 61. Schaafsma M, van den Helder R, Bleeker MCG, Rosier-van Dunné F, van der Avoort IAM, Steenbergen RDM, et al. Experiences and preferences towards collecting a urine and cervicovaginal self-sample among women attending a colposcopy clinic. Preventive Medicine Reports. 2022;26:101749. 62. Jain S, Lin SY, Song W, Su YH. Urine-Based Liquid Biopsy for Nonurological Cancers. Genet Test Mol Biomarkers. 2019;23(4):277-83. 63. Bryzgunova O, Laktionov P. Extracellular nucleic acids in urine: sources, structure, diagnostic potential. Acta Naturae (англоязычная версия). 2015;7(3 (26)):48-54. 64. Hentschel AE, Nieuwenhuijzen JA, Bosschieter J, van Splunter AP, Lissenberg-Witte BI, van der Voorn JP, et al. Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers. Cancers. 2020;12(4):859. 65. Snoek BC, Splunter APV, Bleeker MCG, Ruiten MCV, Heideman DAM, Rurup WF, et al. Cervical cancer detection by DNA methylation analysis in urine. Sci Rep. 2019;9(1):3088. 66. Lin SY, Linehan JA, Wilson TG, Hoon DS. Emerging utility of urinary cell-free nucleic acid biomarkers for prostate, bladder, and renal cancers. European urology focus. 2017;3(23):265-72. 67. Chauhan PS, Shiang A, Alahi I, Sundby RT, Feng W, Gungoren B, et al. Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients. npj Precision Oncology. 2023;7(1):6. 68. Chaudhuri AA, Pellini B, Pejovic N, Chauhan PS, Harris PK, Szymanski JJ, et al. Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management. JCO Precision Oncology. 2020(4):806-17.
RkJQdWJsaXNoZXIy MjY0ODMw